• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients.

作者信息

Kukkonen S T, Haapiainen R K, Franssila K O, Sivula A H

机构信息

Second Department of Surgery, Helsinki University Central Hospital, Finland.

出版信息

World J Surg. 1990 Nov-Dec;14(6):837-41; discussion 841-2. doi: 10.1007/BF01670533.

DOI:10.1007/BF01670533
PMID:2256356
Abstract

The new, age-related TNM classification system of papillary thyroid carcinoma was applied in a retrospective analysis of 199 patients operated on during the 24-year period from 1956 through 1979 at the Second Department of Surgery, Helsinki University Central Hospital. According to the new staging system, 103 patients (under 45 years of age) and 96 T1 patients (45 years of age and older) were categorized into stage I. The incidence of carcinoma-positive cervical lymph nodes was highest among patients under 30 years of age at primary surgery. During the follow-up period of 6-29 years, cervical lymph node involvement was verified at reoperation in 20 patients (10%). Distant metastases (bone or lung) developed in 11 patients (5.5%). Thirty-one patients (16%) died from carcinoma. The prognostic value of stage grouping, in terms of metastatic tendency and cancer mortality, was clearly demonstrated in the present material, suggesting the suitability of this simplified, new, age-related staging system in clinical practice.

摘要

相似文献

1
Papillary thyroid carcinoma: the new, age-related TNM classification system in a retrospective analysis of 199 patients.
World J Surg. 1990 Nov-Dec;14(6):837-41; discussion 841-2. doi: 10.1007/BF01670533.
2
Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping.导致甲状腺乳头状癌预后不良的危险因素:UICC/AJCC TNM分类和分期分组的有效性
World J Surg. 2007 Apr;31(4):838-48. doi: 10.1007/s00268-006-0455-0.
3
Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.乳头状和滤泡状甲状腺癌的病理肿瘤-淋巴结-转移(pTNM)分期:700例患者的回顾性分析
J Clin Endocrinol Metab. 1997 Nov;82(11):3553-62. doi: 10.1210/jcem.82.11.4373.
4
AMES, MACIS and TNM prognostic classifications in papillary thyroid carcinoma.甲状腺乳头状癌中的AMES、MACIS和TNM预后分类。
Anticancer Res. 2003 Sep-Oct;23(5b):4283-8.
5
Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.甲状腺乳头状癌区域淋巴结转移的结外扩展的预后意义
Head Neck. 2015 Sep;37(9):1336-43. doi: 10.1002/hed.23747. Epub 2014 Oct 29.
6
Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases.与甲状腺乳头状癌和滤泡状癌远处转移患者生存相关的因素。
Thyroid. 1999 Dec;9(12):1227-35. doi: 10.1089/thy.1999.9.1227.
7
Prognostic value of the 8 edition of the tumor-node-metastasis classification for patients with papillary thyroid carcinoma: a single-institution study at a high-volume center in Japan.第八版肿瘤-淋巴结-转移分类对甲状腺乳头状癌患者的预后价值:日本一家大型中心的单机构研究
Endocr J. 2018 Jul 28;65(7):707-716. doi: 10.1507/endocrj.EJ18-0019. Epub 2018 Apr 20.
8
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.经单侧耳后入路机器人辅助全甲状腺切除术并改良根治性颈清扫术
Ann Surg Oncol. 2014 Nov;21(12):3872-5. doi: 10.1245/s10434-014-3896-y. Epub 2014 Sep 17.
9
Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.对于年龄小于 45 岁的甲状腺乳头状癌患者,淋巴结转移的存在和数量与生存受损有关。
J Clin Oncol. 2015 Jul 20;33(21):2370-5. doi: 10.1200/JCO.2014.59.8391. Epub 2015 Jun 15.
10
Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.乳头状甲状腺癌的生存分析与分期和复发风险的关系:巴基斯坦 20 年的经验。
Clin Nucl Med. 2016 Aug;41(8):606-13. doi: 10.1097/RLU.0000000000001237.

引用本文的文献

1
Response to Treatment is Highly Predictable in cN0 Patients with Papillary Thyroid Carcinoma.对于cN0期甲状腺乳头状癌患者,治疗反应具有高度可预测性。
World J Surg. 2016 Sep;40(9):2123-30. doi: 10.1007/s00268-016-3507-0.
2
The pros and cons of routine central compartment neck dissection for clinically nodal negative (cN0) papillary thyroid cancer.临床淋巴结阴性(cN0)甲状腺乳头状癌常规中央区颈淋巴结清扫术的利弊
Gland Surg. 2013 Nov;2(4):186-95. doi: 10.3978/j.issn.2227-684X.2013.10.10.
3
The role of prophylactic central neck dissection in differentiated thyroid carcinoma: issues and controversies.

本文引用的文献

1
Papillary cancer of the thyroid; a review of 25 years of experience.甲状腺乳头状癌:25年经验回顾
Cancer. 1958 Sep-Oct;11(5):895-922. doi: 10.1002/1097-0142(195809/10)11:5<895::aid-cncr2820110506>3.0.co;2-v.
2
Papillary thyroid carcinoma: a 10 year follow-up report of the impact of therapy in 576 patients.甲状腺乳头状癌:576例患者治疗效果的10年随访报告
Am J Med. 1981 Mar;70(3):511-8. doi: 10.1016/0002-9343(81)90573-8.
3
Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.甲状腺分化癌治疗的影响:706例病例分析
预防性中央区颈部清扫术在分化型甲状腺癌中的作用:问题与争议。
J Oncol. 2011;2011:127929. doi: 10.1155/2011/127929. Epub 2011 Sep 29.
4
Optimizing the treatment of AMES high-risk papillary thyroid carcinoma.优化AMES高危乳头状甲状腺癌的治疗
World J Surg. 2004 Nov;28(11):1103-9. doi: 10.1007/s00268-004-7420-6.
5
Recurrent or persistent thyroid cancer of follicular cell origin.滤泡细胞起源的复发性或持续性甲状腺癌。
Curr Treat Options Oncol. 2000 Oct;1(4):339-43. doi: 10.1007/s11864-000-0049-2.
6
Differential reactivity of HBME-1 and CD15 antibodies in benign and malignant thyroid tumours. Preferential reactivity with malignant tumours.HBME-1和CD15抗体在甲状腺良恶性肿瘤中的不同反应性。对恶性肿瘤的优先反应性。
Virchows Arch. 1996 Nov;429(4-5):213-9. doi: 10.1007/BF00198336.
7
Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131).复发性甲状腺癌。手术与放射性碘(I131)的作用。
Ann Surg. 1994 Jun;219(6):587-93; discussion 593-5. doi: 10.1097/00000658-199406000-00001.
8
Resection of metastatic thyroid carcinomas to the liver and the kidney: report of a case.
Surg Today. 1994;24(9):844-8. doi: 10.1007/BF01636320.
J Clin Endocrinol Metab. 1983 Jun;56(6):1131-8. doi: 10.1210/jcem-56-6-1131.
4
Changing end results in patients with papillary carcinoma of the thyroid.甲状腺乳头状癌患者的最终结局变化
Surg Gynecol Obstet. 1971 Mar;132(3):460-8.
5
Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment.甲状腺乳头状癌。初次手术治疗后甲状腺复发。
Am J Surg. 1972 Oct;124(4):468-72. doi: 10.1016/0002-9610(72)90068-2.
6
Further evidence of the validity of risk group definition in differentiated thyroid carcinoma.分化型甲状腺癌风险组定义有效性的进一步证据。
Surgery. 1985 Dec;98(6):1171-8.
7
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma.分化型甲状腺癌患者的长期结果及预后因素
Cancer. 1985 Feb 15;55(4):794-804. doi: 10.1002/1097-0142(19850215)55:4<794::aid-cncr2820550418>3.0.co;2-z.
8
Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up.
Cancer. 1986 Apr 1;57(7):1405-14. doi: 10.1002/1097-0142(19860401)57:7<1405::aid-cncr2820570728>3.0.co;2-o.
9
Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients.甲状腺乳头状癌和滤泡状癌。1578例患者的预后因素。
Am J Med. 1987 Sep;83(3):479-88. doi: 10.1016/0002-9343(87)90758-3.
10
Surgical strategy in thyroid carcinoma: a clinical review.
Acta Chir Scand. 1986 May;152:321-38.